SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-18-027496
Filing Date
2018-11-06
Accepted
2018-11-06 17:00:13
Documents
5
Effectiveness Date
2018-11-06

Document Format Files

Seq Description Document Type Size
1 S-8 bold-s8.htm S-8 149332
2 EX-5.1 bold-ex51_6.htm EX-5.1 13422
3 EX-23.2 bold-ex232_8.htm EX-23.2 2321
4 EX-99.2 bold-ex992_7.htm EX-99.2 201542
5 GRAPHIC gr5kj0152uhx000001.jpg GRAPHIC 7122
  Complete submission text file 0001564590-18-027496.txt   377604
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-228208 | Film No.: 181163800
SIC: 2836 Biological Products, (No Diagnostic Substances)